ACTRIMS 2021: Safety and efficacy of disease-modifying therapies in multiple sclerosisMarch 19, 2021Multiple Sclerosis
Neurology ReviewsCan supplementary estrogen relieve MS symptoms in menopausal women?March 17, 2021Multiple Sclerosis
Neurology ReviewsNeurologic drug prices jump 50% in five yearsMarch 16, 2021Business of MedicineEpilepsy & SeizuresMultiple SclerosisParkinson's Disease
Neurology ReviewsErythropoietin falls short of neuroprotection in optic neuritisMarch 12, 2021Multiple Sclerosis
Neurology ReviewsDisease progression and therapy response vary in MS by ethnicityMarch 10, 2021Multiple Sclerosis
Neurology ReviewsInfections – especially urinary and kidney – are higher in MSMarch 9, 2021Multiple Sclerosis
Neurology ReviewsNatalizumab postinfusion reactions rare; is monitoring necessary?March 4, 2021Multiple Sclerosis
Neurology ReviewsNfL levels linked to worse disability in real-world MSMarch 3, 2021Multiple Sclerosis
Neurology ReviewsVitamin D deficiency linked to early cognitive impairment in MSMarch 3, 2021Multiple Sclerosis
